Health Care, News

Bionor Pharma Positioned for Execution of the Kick, the Kill and the Boost Strategy, Aiming Towards a Functional Cure for HIV

Bionor Pharma ASA (OSE: BIONOR) announced today results from the third quarter and first nine months of 2013.

The Q3 report will be presented by webcast 8 November at 8.30 am CET. Link for registration and access to the webcast: http://www.media-server.com/m/p/zovaz8yn
See further information about the webcast and call numbers below.

Download the Q3 report and Q3 presentation.

 

If you would like to find out more about Bionor Pharma, please visit their website here.